Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Covidien has said that one of its subsidiaries has signed a new agreement to supply X-ray contrast imaging agents to customers of MedAssets Supply Chain Systems, a St. Louis-based group purchasing organization.
Subscribe to our email newsletter
The multi-year agreement broadens the scope of Covidien Imaging Solutions products available to MedAssets Supply Chain Systems customers nationwide.
Under the agreement, which became effective on November 1, 2007, Covidien will provide a range of products used to aid in the diagnosis of disease including X-ray contrast agents, sodium chloride injection, 0.9% in Ultraject prefilled syringes and MD-Gastroview (diatrizoate meglumine and diatrizoate sodium solution). Covidien Imaging Solutions also is supplying its full portfolio of contrast media injectors to MedAssets’ customers in accordance with a separate agreement signed earlier this year.
Rick Lytle, vice president and general manager of Covidien Imaging Solutions, US, said: “This agreement enables us to collaborate with MedAssets Supply Chain Systems and its customers to provide world-class imaging products and novel delivery systems that are instrumental in the diagnosis of disease.”